Skip to main content
Fig. 3 | BMC Neurology

Fig. 3

From: Treatment patterns and persistence on disease modifying therapies for multiple sclerosis and its associated factors

Fig. 3

Network analysis of the treatment patterns. Lines on the top of the nodes depict switches from left to right and lines below the nodes depict switches from right to left. FTY: fingolimod; NTZ: natalizumab; IFN: interferons; GA: glatiramer acetate; SUS: suspension; TRF: teriflunomide; DMF: dimethylfumarate; RTX: rituximab; ALZ: alemtuzumab: OCR: ocrelizumab

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us